The Evaluation of Low-Dose Cytarabine in the Treatment of Myelodysplastic Syndromes: A Phase-Iii Intergroup Study

Annals of Hematology - Germany
doi 10.1007/bf01697631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy